Skip to content

AMGN vs BMY: Dividend Comparison

AMGN$458.43
Amgen Inc
Health Care
vs
BMY$60.77
Bristol Myers Squibb Co
Health Care

Dividend data as of

Amgen Inc (AMGN) and Bristol Myers Squibb Co (BMY) are both in the Health Care sector, making them natural rivals for dividend investors. BMY offers a significantly higher 4.00% yield compared to AMGN's 2.17%, a gap of 1.83%. For dividend growth, AMGN leads with a 5-year CAGR of 7.1% versus BMY's 5.1%. Both stocks carry a "Safe" dividend safety rating. Both are classified as Dividend Contenders.

Verdict

Best for Income
BMY
Higher yield at 4.00%
Best for Growth
AMGN
5yr CAGR of 7.1%
Best for Safety
Tie
Similar safety profiles

Track AMGN and BMY in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan (1 portfolio, 10 holdings).

30-day free brokerage sync trial. No credit card. Then from $9.99/month. Choosing a tracker? See the best dividend trackers compared.

Metric
Price
$458.43
$60.77
Dividend Yield
2.17%
4.00%
Annual Dividend
$10.08
$2.52
5yr Div CAGR
7.1%
5.1%
3yr Div CAGR
5.3%
3.4%
Consecutive Years
13
18
Payout Ratio
57.62%
55.88%
P/E Ratio
—
—
Market Cap
—
—
Income on $10k
$217/yr
$400/yr

Yield Analysis

AMGN
2.17%
BMY
4.00%

BMY yields 1.83% more than AMGN. In dollar terms, AMGN pays $10.08/share vs BMY's $2.52/share annually.

Dividend Growth

AMGN 5yr CAGR
7.1%
decelerating
BMY 5yr CAGR
5.1%
decelerating

AMGN: Dividend growth is slowing — the 3-year CAGR of 5.3% trails the 5-year rate of 7.1% and the 10-year rate of 9.5%.

BMY: Dividend growth is slowing — the 3-year CAGR of 3.4% trails the 5-year rate of 5.1% and the 10-year rate of 5.2%.

Dividend Safety

AMGN
Safe
Payout Ratio58%
BMY
Safe
Payout Ratio56%

AMGN: The payout ratio of 58% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 1.7x.

BMY: The payout ratio of 56% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 1.8x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
AMGN
BMY
$10,000
$217/yr
$400/yr
$50,000
$1,086/yr
$2,002/yr
$100,000
$2,171/yr
$4,004/yr

What does $10,000 buy in AMGN vs BMY today?

At $458.43 per share, $10,000 buys about 21.8 shares of Amgen Inc (AMGN). Each share pays $10.08 per year in dividends, so the position starts out generating roughly $220 per year — about $18 a month.

At $60.77 per share, $10,000 buys about 164.6 shares of Bristol Myers Squibb Co (BMY). Each share pays $2.52 per year in dividends, so the position starts out generating roughly $415 per year — about $35 a month.

BMY is the larger income stream from day one: $195 per year more on the same $10,000 invested.

What could $10,000 of AMGN or BMY income look like in 10 years?

Amgen Inc (AMGN) has raised its dividend about 7.1% a year over the past five years. If that pace held, the $217 per year that $10,000 generates today at the current 2.17% yield would reach $433 per year by 2036 — a 4.3% yield on the original cost.

Bristol Myers Squibb Co (BMY) has raised its dividend about 5.1% a year over the past five years. If that pace held, the $400 per year that $10,000 generates today at the current 4.00% yield would reach $662 per year by 2036 — a 6.6% yield on the original cost.

On those trailing rates, BMY pays more in 2036: $662 versus $433 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would AMGN's dividend growth overtake BMY's higher yield?

Not within a realistic holding period. Amgen Inc (AMGN) is growing its dividend faster (7.1% vs 5.1% a year), but the starting-yield gap — 4.00% for BMY vs 2.17% for AMGN — is wide enough that the crossover sits more than 30 years out on trailing rates. For income you plan to spend, BMY's head start is decisive.

Can AMGN and BMY afford their dividends?

Amgen Inc (AMGN) earns $17.25 per share against $10.08 paid out in dividends — 1.7x coverage (a 58% payout ratio).

Bristol Myers Squibb Co (BMY) earns $4.51 per share against $2.52 paid out in dividends — 1.8x coverage (a 56% payout ratio).

Coverage is similar for both, so neither dividend looks meaningfully more stretched than the other on current earnings.

Which fits an early-retirement income portfolio better, AMGN or BMY?

For income you need right now, Bristol Myers Squibb Co (BMY) leads: $100,000 invested today pays about $334 a month at the current 4.00% yield, versus $181 a month from Amgen Inc (AMGN) at 2.17%.

With a decade or more before the income is needed, AMGN's faster dividend growth (7.1% vs 5.1% a year) matters more than the starting yield — raises compound into the larger paycheck over time.

On consistency: AMGN has raised its dividend 13 consecutive years; BMY has raised its dividend 18 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $536/yr in AMGN vs $980/yr in BMY by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.